CHRODIS-PLUS

Europe is paying a heavy price for chronic diseases (CD): it has been estimated that CD cost EU economies 115 billion € or 0.8% of GDP annually; and this figure does not include the additional loss in terms of lower employment rates and productivity of people living with chronic health problems. However, the aspiration is a health-promoting Europe, free of preventable CD, premature death and avoidable disability could be possible. Initiatives on CD should build on four cornerstones: health promotion and primary prevention as a way to reduce the burden of CD; patient empowerment; tackling functional decline and quality of life as the main consequences of CD, and making health systems sustainable and responsive to the aging of our populations associated with the epidemiological transition (an increase in incidence of CD and extended life expectancy) whose consequence is an increasing prevalence of CD. In this Joint Action, CHRODIS-PLUS, our goal is to support Member States through cross-national initiatives identified in JA-CHRODIS to reduce the burden of CD, while assuring health systems sustainability and responsiveness. CHRODIS-PLUS aims to promote the implementation of policies and practices with demonstrated success in each of the four cornerstones mentioned, in closely monitored implementation experiences that can be validated before scaling them up. For this, a total of 42 beneficiaries representing 20 European countries will collaborate to implement pilots and generate practical lessons that could contribute to the uptake and use of CHRODIS-PLUS results. Practices to be implemented will be based on the collection of policies, strategies and interventions that started in JA-CHRODIS and in its outputs such as the Integrated Multimorbidity Care Model or the Recommendations for Diabetes Quality criteria or national plans. During the 36-month life CHRODIS-PLUS will disseminate its activities and monitor and evaluate them to verify the progress and impact of the action. CHRODIS-PLUS will look for synergies with international/regional/local policy initiatives in CD. CHRODIS-PLUS will count on the Governing Board of representatives from European Ministries of Health, key to CHRODIS-PLUS development and sustainability, an Executive Board and a General Assembly where all associated partners will gather. A proposal for the EU added value of cross-country collaboration in the field of CD and the sustainability of the results from JA-CHRODIS and CHRODIS-PLUS beyond 2020, when this project ends, will be approved.

Consortium

INSTITUTO DE SALUD CARLOS III (ISCIII) – Spain
ASOCIACION CENTRO DE EXCELENCIA INTERNACIONAL EN INVESTIGACION SOBRE CRONICIDAD (KRONIKGUNE) – Spain
HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO (CIPH) – Croatia
INSTITUT NATIONAL DU CANCER GIP (INCa) – France
TECHNISCHE UNIVERSITAET DRESDEN (TUD) – Germany
UNIVERSITAET ULM (UULM) – Germany
KLINIKUM DER UNIVERSITAET REGENSBURG (UHREG) – Germany
ARISTOTELIO PANEPISTIMIO THESSALONIKIS (AUTH) – Greece
Orszagos Onkologiai Intezet (OOI) – Hungary
OTTO-VON-GUERICKE-UNIVERSITAET MAGDEBURG (OVGU) – Germany
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (CERTH) – Greece
EMBAETTI LANDLAEKNIS (DOHI) – Iceland
HEALTH SERVICE EXECUTIVE HSE (HSE) – Ireland
INSTITUTE OF PUBLIC HEALTH IN IRELAND LIMITED (IPH) – Ireland
AZIENDA SANITARIA LOCALE TO3 (ASL TO3) – Italy
FORUM EUROPEEN DES PATIENTS (FPE) (EPF) – Luxembourg
FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA (FINCB) – Italy
ISTITUTO SUPERIORE DI SANITA (ISS) – Italy
LIETUVOS SVEIKATOS MOKSLU UNIVERSITETO LIGONINE KAUNO KLINIKOS (KAUNO KLINIKOS) – Lithuania
HIGIENOS INSTITUTAS (HI) – Lithuania
Ministry for Health – Government of Malta (MFH) – Malta
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (RIVM) – Netherlands
FACULTY OF MEDICINE, UNIVERSITY OF BELGRADE (UBEO) – Serbia
INSTITUT ZA JAVNO ZDRAVLJE SRBIJE ‘MILAN JOVANOVIC – BATUT’ (IPHS) – Serbia
MINISTERSTVO ZDRAVOTNICTVA SLOVENSKEJ REPUBLIKY (MoH SK) – Slovakia
NACIONALNI INSTITUT ZA JAVNO ZDRAVJE (NIJZ) – Slovenia
AGENCIA DE QUALITAT I AVALUACIO SANITARIES DE CATALUNYA (AQUAS) – Spain
CONSEJERIA DE SALUD DE LA JUNTA DE ANDALUCIA (CSJA) – Spain
CONSEJERIA DE SANIDAD DE CANTABRIA (CSC) – Spain
INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD (IACS) – Spain
MINISTERO DELLA SALUTE (MoHIT ) – Italy
SEMMELWEIS EGYETEM (SU) – Hungary
VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS (VULSK) – Lithuania
VLAAMS GEWEST (VL O) – Belgium
NATSIONALEN CENTAR PO OBSHTESTVENO ZDRAVE I ANALIZI (NCPHA) – Bulgaria
EUROHEALTHNET ASBL (EHNet) – Belgium
TERVEYDEN JA HYVINVOINNIN LAITOS (THL) – Finland
VILNIAUS UNIVERSITETAS (VU) – Lithuania
MINISTERIO DA SAUDE – REPUBLICA PORTUGUESA (MS) – Portugal
SERVICE PUBLIC FEDERAL SANTE PUBLIQUE, SECURITE DE LA CHAINE ALIMENTAIRE ET ENVIRONNEMENT (BHTC) – Belgium
UNIVERSITA CATTOLICA DEL SACRO CUORE (UCSC) – Italy
NARODOWY INSTYTUT GERIATRII REUMATOLOGII I REHABILITACJI IM.PROF.DR HAB. MED. ELEONORY REICHER (NIGRiR) – Poland